Resmed Inc
OTC:RSMDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Resmed Inc
OTC:RSMDF
|
US |
|
Watkin Jones PLC
F:0W0
|
UK |
|
H
|
HCA Healthcare Inc
XMUN:2BH
|
US |
|
T
|
Trade Desk Inc
F:TT8
|
US |
|
M
|
Mattel Inc
XMUN:MTT
|
US |
|
T
|
TJX Companies Inc
DUS:TJX
|
US |
|
S
|
S&P Global Inc
XMUN:MHL
|
US |
|
Dentsu Group Inc
OTC:DNTUY
|
JP |
|
P
|
Polytec Holding AG
VSE:PYT
|
AT |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RSMDF's stock price target?
Price Target
24.48
USD
According to Wall Street analysts, the average 1-year price target for 
RSMDF is 24.48 USD with a low forecast of 18.05 USD and a high forecast of 34.31 USD.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 9%.